All Posts

PBS access for GLP1 medications may soon become a reality in Australia. Learn what this means for obesity treatment and patient care.

From Personal Blame to Chronic Disease – Why Equity and Inclusivity Matter in Obesity Care

Peptides are increasingly promoted for weight loss and anti-ageing.

Menopause and weight gain are closely linked concerns for many women in their 40s and 50s.

Learn what proper assessment, testing, medications, and follow-up look like in doctor-led obesity care.

Finding Freedom Beyond Calorie-Counting

Wegovy may soon be significantly subsidised for Australians with severe obesity who have experienced a stroke or heart attack.

If you’ve tried to lose weight before and regained it, you’re not alone. Most people struggle not because they lack willpower, but because they’ve never had access to medical, evidence-based care that targets the true drivers of weight gain.

When it comes to managing adiposity-based chronic disease, I have found that a one-size-fits-all approach to nutrition simply does not work. Each person’s body, lifestyle, and health challenges are unique. This is why tailored dietary planning is so important. It allows us to create a nutrition plan that fits your individual needs, preferences, and medical conditions. By focusing on what works best for you, we can support your journey toward lasting health and wellbeing. Per

The Complexity of Obesity Since 1948, the universally accepted definition of obesity has been a condition of excess adiposity that presents a risk to health. Unfortunately, this definition often assumes that obesity is merely a risk factor rather than a disease in its own right. The biology of obesity is complex. For some individuals, living with obesity means experiencing a systemic illness caused solely by their condition. This is known as clinical obesity. The Need for a N

GPs are incentivised by Medicare to provide short consultations. This system can be challenging for many individuals, especially those with complex medical issues like obesity.

Supermarkets play a significant role in shaping our food environment. They often promote unhealthy food options more aggressively than healthier alternatives. This practice contributes to an obesogenic environment.

Whilst it might be tempting to access weight loss medication from a Telehealth-only provider for easy access, some are not doing due diligence to ensure appropriate and safe prescribing.

This recent journal article published in JAMA shows that BMI afterall is a very good approximation of excess adiposity (obesity).

A consensus statement was recently published (USA) about the priorities for good nutrition in people using GLP-1 medication. The statement highlights the key elements of good nutrition and the need for dietary support from healthcare practitioners with expertise and experience in managing GLP-1 therapies.

We call on the Australian Government to provide funded access to safe and effective pharmacotherapies for obesity treatment to improve health outcomes, address inequities and achieve national obesity strategy goals.

Pharma giants are sweating on the results of a federal government request for guidanceon adding weight-loss drugs to the Pharmaceutical Benefits Scheme in a bid to tackle theobesity epidemic. 

Weight-loss drug PBS listing starting to get traction

Push for weight loss drugs PBS listing ramps up